Joseph EdelmanAXSM history

Issuer:
AXSOME THERAPEUTICS INC.
Quarters tracked:
22 (Q1 2019Q1 2026)
Current shares:
149,950
Current value:
$25.34M
Peak shares:
1,105,341 (Q1 2024)
Overall change:
+178%
QuarterSharesValue$/ShareShare ΔΔ%
Q1 2026149,950$25.34M$169.02+1,050+1%
Q4 2025148,900$27.20M$182.6400%
Q3 2025148,900$18.08M$121.45-49,634-25%
Q2 2025198,534$20.73M$104.39-156,573-44%
Q1 2025355,107$41.42M$116.63-308,967-47%
Q4 2024664,074$56.19M$84.61-118,770-15%
Q3 2024782,844$70.35M$89.87+323,733+71%
Q2 2024459,111$36.96M$80.50-646,230-58%
Q1 20241,105,341$88.21M$79.80+67,322+6%
Q4 20231,038,019$82.62M$79.59+556,370+116%
Q3 2023481,649$33.66M$69.89+210,156+77%
Q2 2023271,493$19.51M$71.86+271,493+100%
Q1 2022SOLD-80,420-100%
Q4 202180,420$3.04M$37.7800%
Q3 202180,420$2.65M$32.96-473,488-85%
Q2 2021553,908$37.37M$67.46+553,908+100%
Q3 2020SOLD-50,000-100%
Q2 202050,000$4.11M$82.28+50,000+100%
Q4 2019SOLD-53,879-100%
Q3 201953,879$1.09M$20.2500%
Q2 201953,879$1.39M$25.7400%
Q1 201953,879$767K$14.24NEW